Armistice Capital »

Vistagen Therapeutics Ord shares owned by Armistice Capital

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.0M 300k 3.48
2024-03-31 $1.9M 364k 5.28

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Vistagen Therapeutics Ord

BVF
Stempoint Capital
Vanguard Group
Commodore Capital
Nantahala Capital Management
Sphera Funds Management
Dr. Jeffrey R. Jay, M.D.
BlackRock
BlackRock
Citadel Advisors
Armistice Capital
Geode Capital Management
Susquehanna International
Renaissance Technologies
Goldman Sachs Group

View all funds holding Vistagen Therapeutics Ord